featured
Ibrutinib in Classic and Variant Hairy Cell Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2 Study of Ibrutinib in Classic and Variant Hairy Cell Leukemia
Blood 2021 Mar 22;[EPub Ahead of Print], KA Rogers, LA Andritsos, L Wei, E McLaughlin, AS Ruppert, M Anghelina, JS Blachly, TG Call, D Chihara, AM Dauki, L Guo, SP Ivy, L James, D Jones, RJ Kreitman, G Lozanski, DM Lucas, A Ngankeu, MA Phelps, F Ravandi, C Schiffer, WE Carson Iii, JA Jones, MR GreverFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.